Table 1.
Overall | N-acetylcysteine Study | Modafinil Study | ||
---|---|---|---|---|
Total Study Participants | 129 | 66 | 63 | |
median [IQR] | median | median | Wilcoxon Rank Sum p-value | |
Age | 42 [ 35–47] | 44 [35–44] | 41 [35–44] | 0.037* |
Baseline Monthly Cocaine Days | 12 [8–19] | 12 [8–19] | 12 [8–21] | 0.888 |
Days in Study | 50 [21–56] | 50 [20–55] | 51 [23–56] | 0.563 |
% (n) | % (n) | % (n) | χ2 p-value | |
Gender | ||||
Male | 80% (103) | 80% (53) | 79% (50) | 0.894 |
Female | 20% (26) | 20% (13) | 21% (13) | |
Race | ||||
Black | 49% (63) | 47% (31) | 51% (32) | 0.664 |
White | 51% (66) | 53% (35) | 49% (31) | |
Baseline Cocaine Use | ||||
Light | 35% (45) | 29% (19) | 41% (26) | 0.137 |
Heavy | 65% (84) | 71% (47) | 59% (37) | |
Completion Status | ||||
Completers | 56% (72) | 53% (35) | 59% (37) | 0.515 |
Non-Completers | 44% (57) | 47% (31) | 41% (37) |